CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-29 | KANIA EDWIN M JR Director | Purchase | +74,062 | $22.71 | $1.7M | 302,893 |
| 2021-11-19 | KANIA EDWIN M JR Director | Other disposition | −3,873 | 0 | ||
| 2021-11-19 | KANIA EDWIN M JR Director | Other acquisition | +48,966 | 202,893 | ||
| 2021-11-17 | KANIA EDWIN M JR Director | Other disposition | −779,571 | 0 | ||
| 2021-11-17 | KANIA EDWIN M JR Director | Other disposition | −25,234 | 0 | ||
| 2021-11-17 | KANIA EDWIN M JR Director | Gift | −11,000 | 46,142 | ||
| 2021-11-17 | KANIA EDWIN M JR Director | Other disposition | −46,142 | 0 | ||
| 2021-11-01 | Carey John F VP of Operations | Exercise or conversion | +1,680 | $2.21 | $4K | 1,680 |
| 2021-11-01 | Carey John F VP of Operations | Sale | −1,680 | $28.16 | $47K | 0 |
| 2021-11-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,680 | 12,273 | ||
| 2021-10-01 | Carey John F VP of Operations | Exercise or conversion | +1,680 | $2.21 | $4K | 1,680 |
| 2021-10-01 | Carey John F VP of Operations | Sale | −700 | $31.76 | $22K | 980 |
| 2021-10-01 | Carey John F VP of Operations | Sale | −980 | $32.74 | $32K | 0 |
| 2021-10-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,680 | 13,953 | ||
| 2021-09-15 | Provost Miriam VP of US Regulatory & FDA Rel. | Exercise or conversion | +5,625 | $16.14 | $91K | 12,431 |
| 2021-09-15 | Provost Miriam VP of US Regulatory & FDA Rel. | Sale | −3,877 | $31.34 | $122K | 8,554 |
| 2021-09-15 | Provost Miriam VP of US Regulatory & FDA Rel. | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 9,375 | ||
| 2021-09-07 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +3,941 | $0.28 | $1K | 50,017 |
| 2021-09-07 | Khayal Tamer I Chief Commercial Officer | Sale | −3,941 | $35.08 | $138K | 46,076 |
| 2021-09-07 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,941 | 19,185 |
Page 41 of 49 · 980 trades